Moreover, in patients with EMs, the inhibitory receptor NKG2A and its ligand HLA‐E are highly expressed in the peritoneal fluid, with HLA‐E exhibiting resistance to NK cell‐mediated lysis [336]. The gene discussed is HLA-E; the disease is eosinophilia-myalgia syndrome.